Volume | 146 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
InMode Ltd | INMD | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
21.20 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
13 | 146 | - | 18.57 - 48.25 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
04:16:45 | 10 | $ 21.19 | USD |
InMode (INMD) Options Flow Summary
InMode Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.78B | 83.98M | - | 492.05M | 197.92M | 2.36 | 9.00 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
InMode News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INMD Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 21.50 | 21.75 | 20.41 | 20.82 | 807,043 | -0.30 | -1.40% |
1 Month | 22.01 | 23.46 | 20.00 | 21.57 | 1,181,270 | -0.81 | -3.68% |
3 Months | 20.96 | 26.80 | 19.70 | 22.43 | 1,564,749 | 0.24 | 1.15% |
6 Months | 32.59 | 33.62 | 18.57 | 22.50 | 1,968,356 | -11.39 | -34.95% |
1 Year | 30.48 | 48.25 | 18.57 | 28.54 | 1,658,532 | -9.28 | -30.45% |
3 Years | 68.08 | 180.00 | 18.57 | 43.11 | 1,543,357 | -46.88 | -68.86% |
5 Years | 13.55 | 180.00 | 13.14 | 41.81 | 1,350,663 | 7.65 | 56.46% |
InMode Description
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, Evolve, Evoke, and Morpheus8. The majority of its revenue comes from the United States. |